ZDHHC11B
gene geneOn this page
Summary
ZDHHC11B (zDHHC palmitoyltransferase 11B (putative), HGNC:32962) is a protein-coding gene on chromosome 5p15.33, encoding Probable palmitoyltransferase ZDHHC11B (P0C7U3). Probable palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates and be involved in a variety of cellular processes.
Predicted to enable protein-cysteine S-palmitoyltransferase activity. Predicted to be involved in several processes, including antiviral innate immune response; peptidyl-L-cysteine S-palmitoylation; and positive regulation of defense response to virus by host. Predicted to be located in endosome membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum.
Source: NCBI Gene 653082 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 5 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001351303
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32962 |
| Approved symbol | ZDHHC11B |
| Name | zDHHC palmitoyltransferase 11B (putative) |
| Location | 5p15.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000206077 |
| Ensembl biotype | protein_coding |
| Entrez | 653082 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 2 nonsense_mediated_decay, 2 retained_intron
ENST00000508859, ENST00000522356, ENST00000622126, ENST00000651083, ENST00000651221, ENST00000651714, ENST00000652055, ENST00000962634
RefSeq mRNA: 1 — MANE Select: NM_001351303
NM_001351303
CCDS: CCDS87287
Canonical transcript exons
ENST00000508859 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002082626 | 766698 | 766919 |
| ENSE00002103995 | 710355 | 712282 |
| ENSE00003565060 | 716801 | 716865 |
| ENSE00003841230 | 730434 | 730468 |
| ENSE00003844672 | 767392 | 767524 |
| ENSE00003845003 | 768835 | 768930 |
| ENSE00003845609 | 733752 | 733839 |
| ENSE00003846925 | 741594 | 741628 |
| ENSE00003847016 | 754998 | 755099 |
| ENSE00003847867 | 751133 | 751257 |
| ENSE00003848086 | 745183 | 745298 |
| ENSE00003849291 | 748404 | 748559 |
| ENSE00003849679 | 784668 | 784729 |
| ENSE00003850806 | 755966 | 756144 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 98.17.
FANTOM5 (CAGE): breadth broad, TPM avg 2.8217 / max 268.9793, expressed in 362 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60733 | 2.7205 | 356 |
| 60732 | 0.1012 | 52 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 98.17 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.42 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.97 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.92 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.91 | gold quality |
| cerebellum | UBERON:0002037 | 96.90 | gold quality |
| right uterine tube | UBERON:0001302 | 96.74 | gold quality |
| Ammon’s horn | UBERON:0001954 | 93.89 | gold quality |
| putamen | UBERON:0001874 | 93.84 | gold quality |
| primary visual cortex | UBERON:0002436 | 93.80 | gold quality |
| right frontal lobe | UBERON:0002810 | 93.59 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.35 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 93.16 | gold quality |
| amygdala | UBERON:0001876 | 92.84 | gold quality |
| temporal lobe | UBERON:0001871 | 92.83 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.71 | gold quality |
| apex of heart | UBERON:0002098 | 92.35 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.32 | gold quality |
| brain | UBERON:0000955 | 92.28 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 92.28 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.20 | gold quality |
| hypothalamus | UBERON:0001898 | 92.11 | gold quality |
| substantia nigra | UBERON:0002038 | 91.98 | gold quality |
| pituitary gland | UBERON:0000007 | 91.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.74 | gold quality |
| spinal cord | UBERON:0002240 | 91.73 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 91.55 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 91.03 | gold quality |
| cerebral cortex | UBERON:0000956 | 90.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 90.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.85 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- First, MYC downregulates miR-150 to unleash MYB from the miR-150-mediated repression. Second, MYC induces ZDHHC11 and ZDHHC11B that further ensures the maintenance of high MYB levels (PMID:28331227)
- ZDHHC11B is decreased in lung adenocarcinoma and inhibits tumorigenesis via regulating epithelial-mesenchymal transition. (PMID:37434393)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zdhhc11 | ENSDARG00000076202 |
| mus_musculus | Zdhhc11 | ENSMUSG00000069189 |
| rattus_norvegicus | Zdhhc11 | ENSRNOG00000039743 |
| drosophila_melanogaster | Dnz1 | FBGN0027453 |
| drosophila_melanogaster | CG1407 | FBGN0033474 |
| drosophila_melanogaster | CG17287 | FBGN0034202 |
| caenorhabditis_elegans | dhhc-7 | WBGENE00007637 |
| caenorhabditis_elegans | dhhc-12 | WBGENE00010323 |
| caenorhabditis_elegans | dhhc-2 | WBGENE00012948 |
| caenorhabditis_elegans | WBGENE00014075 | |
| caenorhabditis_elegans | WBGENE00016620 | |
| caenorhabditis_elegans | WBGENE00020066 |
Paralogs (17): ZDHHC6 (ENSG00000023041), ZDHHC15 (ENSG00000102383), ZDHHC2 (ENSG00000104219), ZDHHC4 (ENSG00000136247), ZDHHC7 (ENSG00000153786), ZDHHC1 (ENSG00000159714), ZDHHC12 (ENSG00000160446), ZDHHC3 (ENSG00000163812), ZDHHC19 (ENSG00000163958), ZDHHC14 (ENSG00000175048), ZDHHC21 (ENSG00000175893), ZDHHC22 (ENSG00000177108), ZDHHC20 (ENSG00000180776), ZDHHC23 (ENSG00000184307), ZDHHC9 (ENSG00000188706), ZDHHC11 (ENSG00000188818), ZDHHC18 (ENSG00000204160)
Protein
Protein identifiers
Probable palmitoyltransferase ZDHHC11B — P0C7U3 (reviewed: P0C7U3)
Alternative names: Zinc finger DHHC domain-containing protein 11B
All UniProt accessions (5): P0C7U3, A0A494BZX9, A0A494C0T6, A0A494C1T0, A0A7P0TA36
UniProt curated annotations — full annotation on UniProt →
Function. Probable palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates and be involved in a variety of cellular processes. May play a role in cell proliferation.
Subcellular location. Membrane.
Domain organisation. The DHHC domain is required for palmitoyltransferase activity.
Similarity. Belongs to the DHHC palmitoyltransferase family.
RefSeq proteins (1): NP_001338232* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001594 | Palmitoyltrfase_DHHC | Domain |
| IPR039859 | PFA4/ZDH16/20/ERF2-like | Family |
Pfam: PF01529
Catalyzed reactions (Rhea), 1 shown:
- L-cysteinyl-[protein] + hexadecanoyl-CoA = S-hexadecanoyl-L-cysteinyl-[protein] + CoA (RHEA:36683)
UniProt features (14 total): transmembrane region 5, sequence variant 3, compositionally biased region 2, chain 1, active site 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7U3-F1 | 79.81 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 155 (s-palmitoyl cysteine intermediate)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOBP_PROTEIN_TARGETING, GOBP_PROTEIN_TARGETING_TO_MEMBRANE, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_DEFENSE_RESPONSE_TO_VIRUS, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_RESPONSE_TO_VIRUS, GOMF_S_ACYLTRANSFERASE_ACTIVITY, GOMF_PALMITOYLTRANSFERASE_ACTIVITY, GOMF_ACYLTRANSFERASE_ACTIVITY, NFKBIA_TARGET_GENES, DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION, GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE, MYOCD_TARGET_GENES
GO Biological Process (2): protein targeting to membrane (GO:0006612), antiviral innate immune response (GO:0140374)
GO Molecular Function (4): protein-cysteine S-palmitoyltransferase activity (GO:0019706), palmitoyltransferase activity (GO:0016409), transferase activity (GO:0016740), acyltransferase activity (GO:0016746)
GO Cellular Component (3): endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| protein targeting | 1 |
| establishment of protein localization to membrane | 1 |
| innate immune response | 1 |
| defense response to virus | 1 |
| palmitoyltransferase activity | 1 |
| protein-cysteine S-acyltransferase activity | 1 |
| acyltransferase activity, transferring groups other than amino-acyl groups | 1 |
| catalytic activity | 1 |
| transferase activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
192 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZDHHC11B | SPDYE11 | P0DTA3 | 576 |
| ZDHHC11B | TMEM170A | Q8WVE7 | 507 |
| ZDHHC11B | ZDHHC13 | Q8IUH4 | 490 |
| ZDHHC11B | BTBD6 | Q96KE9 | 477 |
| ZDHHC11B | ZDHHC3 | Q9NYG2 | 433 |
| ZDHHC11B | ZDHHC24 | Q6UX98 | 431 |
| ZDHHC11B | PGPEP1 | Q9NXJ5 | 417 |
| ZDHHC11B | ZDHHC22 | Q8N966 | 416 |
| ZDHHC11B | RCCD1 | A6NED2 | 382 |
| ZDHHC11B | ZFP30 | Q9Y2G7 | 348 |
| ZDHHC11B | PPT1 | P50897 | 332 |
| ZDHHC11B | CELA3B | P08861 | 329 |
| ZDHHC11B | ZNF512 | Q96ME7 | 323 |
| ZDHHC11B | CLPTM1L | Q96KA5 | 313 |
| ZDHHC11B | SUPT4H1 | P63272 | 306 |
IntAct
0 interactions, top by confidence:
BioGRID (1): ZDHHC11B (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IDP3, A0A0R4IF99, A0PK84, B0S5D5, E7F021, E7F587, F1Q7H8, F1QAM1, F1QGD2, F1QHM7, F1QX91, F1QXD3, F1RE57, O74384, P0C7U3, P42836, Q06551, Q0VC89, Q2TGI8, Q2TGJ4, Q500Z2, Q58DT3, Q5BLG4, Q5FVR1, Q5FWL7, Q5M757, Q5W0Z9, Q5Y5T1, Q5Y5T3, Q6CPU8, Q6DHI1, Q6FSS4, Q6FW70, Q750R7, Q75AW7, Q7XA86, Q8BGJ0, Q8I0G4, Q8VYP5, Q91WU6
Diamond homologs: E7EZI4, E7F4Z4, P0C7U3, Q14AK4, Q8R0N9, Q8WTX9, Q9H8X9, Q8L5Y5, A0A0R4IQZ2, A0PK84, A5WVX9, B8A4F0, C8VCL4, E9PTT0, F1QAM1, F1QHM7, F1QX91, O60069, P0CS66, P0CS67, Q03289, Q04629, Q09701, Q10L01, Q2TGI8, Q2TGJ4, Q2TGK3, Q4I8B6, Q4IA62, Q4P6L3, Q4R690, Q4WZL8, Q4X251, Q550R7, Q552M6, Q554E7, Q58DT3, Q59QL0, Q5ADN9, Q5B0V6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 0 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 624532 | GRCh37/hg19 5p15.33(chr5:52186-4163906)x1 | Likely pathogenic |
SpliceAI
2686 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:730425:CGAA:C | donor_gain | 1.0000 |
| 5:730432:A:AC | donor_gain | 1.0000 |
| 5:730432:AC:A | donor_gain | 1.0000 |
| 5:730433:C:CC | donor_gain | 1.0000 |
| 5:730433:CC:C | donor_gain | 1.0000 |
| 5:745179:GTACC:G | donor_loss | 1.0000 |
| 5:745181:A:C | donor_loss | 1.0000 |
| 5:745182:C:CA | donor_loss | 1.0000 |
| 5:745221:T:A | donor_gain | 1.0000 |
| 5:745294:GGCCT:G | acceptor_gain | 1.0000 |
| 5:745295:GCCT:G | acceptor_gain | 1.0000 |
| 5:745296:CCTC:C | acceptor_gain | 1.0000 |
| 5:745297:CT:C | acceptor_gain | 1.0000 |
| 5:745299:C:CC | acceptor_gain | 1.0000 |
| 5:745299:CTGG:C | acceptor_loss | 1.0000 |
| 5:745300:T:A | acceptor_loss | 1.0000 |
| 5:748402:A:AC | donor_gain | 1.0000 |
| 5:748403:C:CC | donor_gain | 1.0000 |
| 5:748403:CT:C | donor_gain | 1.0000 |
| 5:712283:C:CC | acceptor_gain | 0.9900 |
| 5:716880:C:CT | acceptor_gain | 0.9900 |
| 5:716881:A:T | acceptor_gain | 0.9900 |
| 5:730424:A:AC | donor_gain | 0.9900 |
| 5:730425:C:CC | donor_gain | 0.9900 |
| 5:730429:CTT:C | donor_loss | 0.9900 |
| 5:730431:TACCC:T | donor_loss | 0.9900 |
| 5:745192:T:TA | donor_gain | 0.9900 |
| 5:745226:A:AC | donor_gain | 0.9900 |
| 5:745227:C:CC | donor_gain | 0.9900 |
| 5:748398:ACATA:A | donor_loss | 0.9900 |
AlphaMissense
2441 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:755048:G:C | F151L | 0.976 |
| 5:755048:G:T | F151L | 0.976 |
| 5:755050:A:G | F151L | 0.976 |
| 5:755989:G:C | F126L | 0.949 |
| 5:755989:G:T | F126L | 0.949 |
| 5:755991:A:G | F126L | 0.949 |
| 5:756002:A:G | I122T | 0.948 |
| 5:755081:G:C | H140Q | 0.947 |
| 5:755081:G:T | H140Q | 0.947 |
| 5:755084:T:A | K139N | 0.943 |
| 5:755084:T:G | K139N | 0.943 |
| 5:755978:C:G | C130S | 0.924 |
| 5:755979:A:T | C130S | 0.924 |
| 5:755067:T:A | N145I | 0.919 |
| 5:756002:A:C | I122S | 0.917 |
| 5:745283:G:A | T267I | 0.915 |
| 5:755987:C:G | C127S | 0.914 |
| 5:755988:A:T | C127S | 0.914 |
| 5:755061:C:G | C147S | 0.910 |
| 5:755062:A:T | C147S | 0.910 |
| 5:755063:C:A | K146N | 0.910 |
| 5:755063:C:G | K146N | 0.910 |
| 5:755083:G:C | H140D | 0.902 |
| 5:755987:C:T | C127Y | 0.898 |
| 5:755066:A:C | N145K | 0.894 |
| 5:755066:A:T | N145K | 0.894 |
| 5:756028:G:C | F113L | 0.886 |
| 5:756028:G:T | F113L | 0.886 |
| 5:756030:A:G | F113L | 0.886 |
| 5:756002:A:T | I122N | 0.879 |
dbSNP variants (sampled 300 via entrez): RS1000423341 (5:724995 A>G), RS1000734327 (5:773928 C>A,G,T), RS1000784782 (5:745819 C>T), RS1000859682 (5:747043 T>C), RS1001104322 (5:772546 G>A), RS1001330191 (5:718488 A>G), RS1001915534 (5:741679 C>T), RS1001933478 (5:714283 C>G,T), RS1002137059 (5:767462 A>G), RS1002428484 (5:715863 C>T), RS1002706807 (5:761660 T>A,C), RS1002738103 (5:762883 A>C), RS1002866476 (5:732961 G>C), RS1002884611 (5:710063 T>G), RS1002944259 (5:785030 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90020029_1127 | Waist circumference adjusted for body mass index | 7.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| di-n-butylphosphoric acid | affects expression | 1 |
| clothianidin | decreases expression | 1 |
| abrine | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.